A Phase II Study of SI-613 in Patients with Knee Osteoarthritis (repeat-dose study)

Trial Profile

A Phase II Study of SI-613 in Patients with Knee Osteoarthritis (repeat-dose study)

Completed
Phase of Trial: Phase II/III

Latest Information Update: 13 Jun 2016

At a glance

  • Drugs SI 613 (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Seikagaku Corporation
  • Most Recent Events

    • 09 Jun 2016 Status changed from active, no longer recruiting to completed.
    • 06 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan
    • 15 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top